Evaluation of Quality of Vision and Visual Outcomes with Bilateral Implantation of a Non-Diffractive Extended Vision Intraocular Lens with a Target of Slight Myopia in the Non-Dominant Eye

Figures & data

Figure 1 Distribution of postoperative mean spherical equivalent refraction by refractive target.

Figure 2 Monocular visual acuity by test distance and refractive target.

Abbreviation: logMAR, log of the minimum angle of resolution.

Figure 3 Binocular visual acuity by test distance and correction.

Abbreviation: logMAR, log of the minimum angle of resolution.

Table 1 Summary Results for the PRSIQ (n = 32)

	Distance (4 m)	Intermediate (66 cm)	Near (40 cm)	Overall
No need for glasses	84%	88%	63%
Never wear glasses, or wear only a little	88%	88%	75%	81%
Function comfortably without glasses all or most of the time	88%	91%	75%	78%
Completely or mostly satisfied with vision without glasses	84%	81%	72%	84%

Abbreviation: PRSIQ, patient reported spectacle independence questionnaire.

Table 2 Summary of IOLSAT Questionnaire Results (n = 33)

		Percentage of Subjects Rarely or Never Needing Glasses		Percentage Reporting “Good” or “Very Good” Vision without Glasses
Condition		Current	Vivity SSE*	Current	Vivity SSE*
Overall		70	45.1
Bright Light	Distance (“far away”)	85	94.1	85	93.7
	Intermediate (“arm’s length”)	85	87.2	94	91.6
	Near (“up close”)	73	46.1	70	57.3
Dim Light	Distance (“far away”)	85	93.2	79	87.5
	Intermediate (“arm’s length”)	88	84.3	76	83.4
	Near (“up close”)	58	39.2	52	37.5

Notes: *PMA P930014/S126: FDA Summary of Safety and Effectiveness Data from US FDA. AcrySof™ IQ Vivity™ extended vision Intraocular Lens (IOL): Summary of safety and effectiveness data. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf/P930014S126B.pdf. Tables 32,33 6M.¹⁹

Table 3 Summary of QUVID Questionnaire Results (n = 33)

Type	Frequency		Severity		Degree of Bother
	“Never” or “Rarely”	“Always” or “Most of the Time”	“None” or “a Little”	“Moderate” or “Severe”	“Not at All” or “a Little”	“Quite a Bit” or “Very Much”
Blur	76%	3%	67%	18%	76%	9%
Double vision	97%	0%	97%	0%	97%	0%
Glare	58%	15%	52%	24%	79%	6%
Halos	55%	18%	52%	33%	70%	21%
Haze	82%	6%	79%	15%	85%	3%
Shadow	85%	3%	94%	3%	97%	0%
Starbursts	39%	39%	36%	55%	67%	18%

US FDA. AcrySof™ IQ Vivity™ extended vision Intraocular Lens (IOL): Summary of safety and effectiveness data. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf/P930014S126B.pdf. Accessed March 7, 2021.

 Google Scholar